Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2

被引:124
作者
Chen, ZB [1 ]
Koralov, SB [1 ]
Kelsoe, G [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA
关键词
complement; autoantibody; glomerulonephritis; splenomegaly; immune complex;
D O I
10.1084/jem.192.9.1339
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The complement system enhances antibody responses to T-dependent antigens, but paradoxically, deficiencies in C1 and C4 are strongly linked to autoantibody production in humans. In mice, disruption of the C1qa gene also results in spontaneous autoimmunity. Moreover, deficiencies in C4 or complement receptors 1 and 2 (CR1/CR2) lead to reduced selection against autoreactive B cells and impaired humoral responses. These observations suggest that C1 and C4 act through CR1/CR2 to enhance humoral immunity and somehow suppress autoimmunity. Here we report high titers of spontaneous antinuclear antibody (ANA) in C4(-/-) mice. This systemic lupus erythematosus-like autoimmunity is highly penetrant; by 10 mo of age, all C4(-/-) females and most males produced ANA. In contrast, titers and frequencies of ANA in Cr2(-/-) mice, which are deficient in CR1 and CR2, never rose significantly above those in normal controls. Glomerular deposition of immune complexes (ICs), glomerulonephritis, and splenomegaly were observed in C4(-/-) but not Cr2(-/-) mice. C4(-/-), but not Cr2(-/-), mice accumulate activated T and B cells. Clearance of circulating ICs is impaired in preautoimmune C4(-/-), but not Cr2(-/-), mice. C4 deficiency causes spontaneous, lupus-like autoimmunity through a mechanism that is independent of CR1/CR2.
引用
收藏
页码:1339 / 1351
页数:13
相关论文
共 69 条
  • [51] COMPLEMENT DEFICIENCY STATES AND INFECTION - EPIDEMIOLOGY, PATHOGENESIS AND CONSEQUENCES OF NEISSERIAL AND OTHER INFECTIONS IN AN IMMUNE-DEFICIENCY
    ROSS, SC
    DENSEN, P
    [J]. MEDICINE, 1984, 63 (05) : 243 - 273
  • [52] Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
    Sauter, B
    Albert, ML
    Francisco, L
    Larsson, M
    Somersan, S
    Bhardwaj, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (03) : 423 - 433
  • [53] THE CENTRAL ROLE OF FOLLICULAR DENDRITIC CELLS IN LYMPHOID-TISSUES
    SCHRIEVER, F
    NADLER, LM
    [J]. ADVANCES IN IMMUNOLOGY, 1992, 51 : 243 - 284
  • [54] SCHUR PH, 1986, ANNU REV MED, V37, P333
  • [55] Light chain usage in anti-double-stranded DNA B cell subsets: Role in cell fate determination
    Spatz, L
    Saenko, V
    Iliev, A
    Jones, L
    Geskin, L
    Diamond, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (07) : 1317 - 1326
  • [56] COMPLEMENT COMPONENTS, C1 ACTIVATION AND DISEASE-ACTIVITY IN SLE
    STURFELT, G
    SJOHOLM, AG
    SVENSSON, B
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1983, 70 (01): : 12 - 18
  • [57] ANTI-DSDNA AND COMPLEMENT PROFILES AS PROGNOSTIC GUIDES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    SWAAK, AJG
    AARDEN, LA
    STATIUSVANEPS, LW
    FELTKAMP, TEW
    [J]. ARTHRITIS AND RHEUMATISM, 1979, 22 (03): : 226 - 235
  • [58] Takahashi K, 1997, J IMMUNOL, V159, P1557
  • [59] Tas SW, 1999, J IMMUNOL, V163, P5056
  • [60] A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo
    Taylor, PR
    Carugati, A
    Fadok, VA
    Cook, HT
    Andrews, M
    Carroll, MC
    Savill, JS
    Henson, PM
    Botto, M
    Walport, MJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (03) : 359 - 366